Plot options



2. Select dataset:

Survival options

Survival INFO
Split patients by
Auto select best cutoff INFO
Trichotomization :  INFO

Restrict analysis to subtypes...

ER status:
PGR status:
HER2 status:
Molecular subtype: INFO

Lymph node status:

Restrict analysis to selected cohorts...


Compare datasets

METABRIC: long follow-up (median: 94 months), average characteristics (78% ER positive, 12% HER2 positive), treatment data available for this dataset only!
TCGA: very short follow-up (median only 25 months), no grade.
GSE40267: almost exclusively ER negative patients (92%).
GSE19783: nodal status not available, 38% ER negative, high proportion of HER2 positive patients (18%).

n = number of patients with available clinical data

Please note: the generated p value does not include correction for multiple hypothesis testing by default.

Please kindly cite our paper to support further development: Lanczky A, Nagy A, Bottai G, Munkacsy G, Paladini L, Szabo A, Santarpia L, Gyorffy B. miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2,178 breast cancer patients, Breast Cancer Res Treat. 2016;160(3):439-446. Copyright © 2009-2022 | Contact | Sitemap